Li et al. (2018) supported our finding and detected that serum TK1 concentration was a reliable prognostic biomarker for prostate cancer, associated with Gleason score, making it valuable in predicting disease severity and progression13. The gene discussed is TK1; the disease is Familial prostate cancer.